6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists
Details for Australian Patent Application No. 2011202788 (hide)
International Classifications
Event Publications
30 June 2011 Application Open to Public Inspection
Published as AU-B-2011202788
30 June 2011 Complete Application Filed
3 November 2011 Section 223 Application Allowed
Eli Lilly and Company The time in which to make a further application for a divisional patent has been extended to 17 Jun 2011. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
26 April 2012 Application Accepted
Published as AU-B-2011202788
23 August 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2011202789-Solar heat-utilizing water heater system
2011202787-Method and composition for transdermal drug delivery
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser